Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Britt Koskella maintains a patent portfolio in the Biotechnology & Pharmaceuticals sector with 1 pending office action. This prosecution activity is managed by 1 distinct examiner, BLUMEL, BENJAMIN P, who is currently the busiest examiner for the portfolio. The pending office action is situated within a distinct art unit, showing a focused examination path.
BLUMEL, BENJAMIN P is responsible for the busiest examiner pending action, representing the entirety of the current workload. This concentration in a distinct art unit suggests the underlying technology is highly specialized. Having a distinct examiner assigned to the pending office action ensures a singular point of contact during the prosecution process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BLUMEL, BENJAMIN P | 1 | 70.7% | +30.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17058565 | VIRUS-LIKE PARTICLE COMPOSITIONS AND METHODS OF USING SAME | BLUMEL, BENJAMIN P | — |
| Art Unit | Apps |
|---|---|
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17058565 | VIRUS-LIKE PARTICLE COMPOSITIONS AND METHODS OF USING SAME | BLUMEL, BENJAMIN P | 1671 | §102Other | Final Rejection | — | Pending | Nov 24, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBritt Koskella has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Benjamin P Blumel has the most, with 1 of Britt Koskella's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
